TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international audience of biologists and clinicians, including those still in training. Chairs: Pierre Fenaux, Katharina Götze, Mikkael Sekeres

Date: Friday 12 - Sunday 14 April 2024
Venue: Budapest Marriott Hotel, Budapest

This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease. New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.

Posters and Brief Oral Communications
Registered participants are invited to submit their abstracts. Selected abstracts are eligible for an oral or a poster presentation. Call for abstracts: deadline 15 January 2024.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in training

Learning Objectives
Upon completion of this CME activity, participants should be able to:

  • Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis.
  • Improve ability to analyse prognostic factors, including new ones (revised IPSS, molecular analysis).
  • Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
  • Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.
  • Scientific Topics
    The sinister origins of MDS
  • The interplay between MDS, inflammatory, and immune abnormalities
  • What's in a name? Classifying MDS
  • New tools to explore MDS
  • Special populations
  • Treatment of lower-risk MDS
  • Treatment of higher-risk MDS
  • Transplantation
  • Clinical trials in MDS/CMML: cooperative groups

The program will include:

  • Plenary Sessions
  • Panel Discussions
  • Simultaneous Meet the Expert Sessions
  • Poster Walks
  • Brief Oral Communications

For further information and to register for the event please visit the conference website

External Events

Mar 24
1
8
22
23
Apr 24
12
22
March 1st 2024
FRCPath Haemostasis and Thrombosis Training and...
The course is suitable for SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, sci...
Details
March 8th 2024
ESH 3rd Translational Research Conference: Chro...
ESH Translational Research Conferences propose programmes of leading-edge basic and clinical science, as well as oppo...
Details
March 22nd 2024
Advanced Haemostasis and Thrombosis Course
A two-day intensive online course run by previous Royal College examiners aimed at candidates sitting the part 2 FRCP...
Details
March 23rd 2024
Spring 2024 UCLH FRCPath Part 2 Revision Course
Intensive two-day course held at UCLH on a Saturday and Sunday to prepare candidates about to sit the Part 2 FRCPath...
Details
April 12th 2024
ESH 9th Translational Research Conference: Myel...
TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science,...
Details
April 22nd 2024
BGS Transfusion
BGS Transfusion is a three-day symposium aimed at all levels of staff working in blood transfusion.
Details